Epigenetics refers to heritable changes in phenotype without alterations to the genotype. Epigenetic changes involve two main mechanisms: DNA methylation and histone modification. Methylation of DNA at cytosine bases is the best-studied epigenetic process to date. CpG methylation states are thought to be maintained throughout cell divisions. However, loss of DNA methylation or DNA demethylation has been observed in specific stages of mammalian development. Such prominent examples of developmental DNA demethylation processes occur in developing primordial germ cells and in preimplantation embryos. However, little is known about DNA methylation changes of other tissues in mammalian development. Therefore, the first aim of this PhD study was to investigate changing nuclear distributions and levels of DNA methylation during development in order to discover dynamic variations amongst developing mouse tissues. In addition, a transgenic MBD-GFP mouse was employed to visualise DNA methylation in tissues. Several hypothetical mechanisms for the enzymatic removal of 5mC have been proposed. One of the proposed candidates is Tet-mediated successive oxidation of 5mC to generate 5hmC, 5fC and 5caC. 5hmC has therefore been considered as a transient intermediate in an active cytosine demethylation pathway. Nevertheless, some studies suggest that 5hmC may also function as an epigenetic modification in its own right. Thus, the second aim of this study was to address the research question of how and where 5hmC originates during development. In order to be able to identify tissues undergoing dynamic nuclear changes in DNA methylation and hydroxymethylation states during early mouse development, new working protocols for immunodetection of 5mC and 5hmC on tissue cryosections were required. The protocol optimisation for 5mC immunodetection is discussed in greater detail in Chapter 3. It was found that DNA methylation immunostaining of cryosections required heat-mediated DNA denaturation, which was partly compatible with protein immunostaining. Next, Chapter 4 focuses on identifying tissues undergoing dynamic changes in 5mC and 5hmC patterns during development from E9.5 to E14.5 mouse embryonic stages, using optimised immunohistochemistry protocols. These protocols revealed interesting dynamic observations of 5mC and 5hmC in the developing cerebral neocortex, surface ectoderm, liver, red blood cells, diaphragm and heart. These findings suggested that dynamic changes of 5mC and 5hmC during neocortical and compact myocardial development were in good agreement with a model where the formation of 5hmC may correlate with the loss of old 5mC, but the observations were also consistent with an involvement of de novo methylation in the generation of 5hmC. In other developing tissues, including surface ectoderm, liver, red blood cells, diaphragm and cardiac trabeculae, dynamic changes in 5mC and 5hmC levels were in line with a model where the 5hmC may act as a new epigenetic mark that functions independently. The optimised protocol also confirmed DNA demethylation of the germ cells at E12.5. The presence of three Tet family enzymes (Tet1, Tet2, Tet3) and de novo methyltransferase DNMT3A in mouse E12.5 tissues is reported in the second part of Chapter 4. It was found that Tet1, Tet2, Tet3 and Dnmt3a were present at detectable levels in neocortex, liver, diaphragm and heart. Contrastingly, no apparent signals for Tet1, Tet2, Tet3 and Dnmt3a were observed in red blood cells. This result was expected due to the very low levels of 5hmC staining in E12.5 red blood cells. The third aim of the present study was to investigate the existence of crosstalk between various epigenetic mechanisms. Thus, Chapter 5 focuses on exploring the relationship between 5mC and repressive histone marks, H3K9me3 and H3K27me3. Histone methylation dynamics at H3K9 and H3K27 were observed during mouse fetal development in neocortex and heart. The overall distribution patterns of H3K9me3 and H3K27me3 demonstrated strong association with developmental changes in 5mC, suggesting that these three repressive epigenetic marks work in concert to establish a silenced state of heterochromatin. Chapter 6, on the other hand, focuses on visualising DNA methylation in tissues using mouse transgenic tools. It was found that brain, liver, heart and neural tube expressed high levels of GFP. But no apparent developmental dynamics of GFP was observed. In conclusion, this study will contribute scientific understanding of dynamic DNA methylation and nuclear heterochromatin organisation during mammalian development, and its role in the specification and maintenance of cell lineages forming tissues and organs. This knowledge will provide insight into current barriers to cell fate reprogramming, which will be of benefit to cell regenerative biomedical technologies.

Fetal exposure to excess glucocorticoid is associated with low birth weight and increased cardiovascular disease risk in first generation offspring. Such phenotypes can be produced experimentally through the administration of the synthetic glucocorticoid dexamethasone (Dex) to pregnant rats during the last week of gestation. These ‘programmed effects’ can be transmitted to a second generation through both maternal and paternal lines. The overall hypothesis for this thesis was that the transmission of programmed effects through the male line may result from alterations in fetal germ cells, which form sperm in adulthood. Epigenetic reprogramming of germ cells is characterised by the genome-wide erasure and subsequent re-establishment of 5-methylcytosine (5mC), however this process has not previously been described for the rat. Furthermore, the involvement of more recently identified cytosine modifications; 5-hydroxymethylcytosine (5hmC), 5- formylcytosine (5fC) and 5-carboxylcytosine (5caC), has not been characterised during germ cell ontogeny. Using immunofluorescence to study DNA modifications during late gestation I identified that 5hmC, 5fC and 5caC were present between e14.5 and e16.5 but absent thereafter. In contrast, 5mC was absent during this time but remethylation was noted from e19.5 onwards. Prenatal Dex exposure was associated with the presence of significantly more 5mC-positive germ cells at e19.5 relative to controls. This difference did not persist at e20.5 suggesting that Dex exposure promotes premature global remethylation. The mechanisms for this are unclear since there were no differences between groups in the localisation of the DNA methyltransferases DNMT3a and 3b, or in markers of normal testis maturation. To enable the study of gene-specific changes in DNA methylation in the germline a colony of Germ Cell Specific-Enhanced Green Fluorescent Protein (GCS-EGFP) rats was established and characterised. GCS-EGFP rats had a transgenerational decrease in pup weight with Dex exposure, as in Wistar rats. The expression of both established and novel candidate genes was compared between strains. Multiple genes across different pathways had altered expression, with some affected in both Wistar and GCS-EGFP rats, whilst other differences were strain-specific. Enhanced Reduced Representation Bisulfite Sequencing was performed on liver and fetal germ cells from males exposed to Dex in utero to explore effects on DNA methylation. These studies confirm that epigenetic reprogramming occurs in the rat and that this process may be susceptible to modification by prenatal Dex exposure. GCS-EGFP rats also exhibited a Dex programming phenotype, with decreased pup weight and altered liver gene expression. The use of this unique strain of rats will permit dissection of the mechanisms for the transmission of programmed phenotypes across generations.

Transcriptional elongation is a crucial step in eukaryotic gene regulation whose mis-regulation leads to cellular pathologies. This makes it quite imperative to aim for a better understanding of the processes regulating transcriptional elongation. An important process promoting the association of RNA Polymerase II (RNAPII) with the coding region of the active gene and hence transcriptional elongation is the monoubiquitination of histone H2B at lysine 123. A complex of an E2 conjugase, Rad6p, and an E3 ligase, Bre1p, is essential for this process. Consistent with the role of histone H2B monoubiquitination in promoting the association of RNAPII with the active gene, this process was found to be impaired in the absence of Rad6p or point mutation of lysine 123 to arginine (H2B-K123R). Intriguingly, the association of RNAPII with the coding region of the active gene was not impaired in the absence of Bre1p, even though Bre1p is essential for histone H2B monoubiquitination. However, deletion of Bre1p’s RING domain that is essential for histone H2B monoubiquitination led to an impaired RNAPII association with the active gene. This observation indicates a role of the non-RING domain of Bre1p in repressing the association of RNAPII with the active gene, resulting in no net decrease in RNAPII occupancy in the absence of Bre1p. Taken together, my results implicated both the stimulatory and repressive roles of the histone H2B ubiquitin ligase Bre1p in regulation of RNAPII association with the coding regions of active genes and hence transcriptional elongation. Interestingly, my work also revealed that for efficient transcriptional elongation by histone H2B monoubiquitination, its optimum level needs to be maintained by a proper balance between Rad6p-Bre1p-mediated ubiquitination and de-ubiquitination (DUB) by the DUB module of SAGA. It was found that Sus1p, a subunit of the DUB module, promotes transcriptional elongation, DNA repair and replication via regulation of histone H2B DUB. In addition to Rad6p- Bre1p and the DUB module, global level of histone H2B monoubiquitination is also critically regulated by Cdk9, a kinase essential for phosphorylation of the serine 2 residue in the C-terminal domain (CTD) of RNAPII, which promotes transcriptional elongation. Apart from serine phosphorylation, proline residues at RNAPII-CTD undergo isomerization by proline isomerases, which also regulate transcription. One of the proline isomerases, Rrd1p, has been previously implicated in transcription in response to rapamycin treatment. Based on this fact and Rrd1p’s known interaction with RNAPII-CTD, we predicted that Rrd1p might regulate transcription independently of rapamycin treatment. In agreement with this hypothesis, our work revealed Rrd1p’s role in facilitating transcription of both rapamycin responsive and non-responsive genes in the absence of rapamycin treatment. Consistently, the absence of Rrd1p led to an impaired nucleosomal disassembly at the active gene, which correlates with the role of Rrd1p in promoting transcription. This is because maintenance of proper nucleosomal dynamics is essential for efficient transcription. It is known that transcriptional elongation is facilitated by the regulation of nucleosomal dynamics via the histone chaperone, FACT. Efficient chromatin reassembly in the wake of elongating RNAPII contributing to the fidelity of transcription is promoted by FACT. Being evolutionarily conserved among eukaryotes, FACT is also known to regulate DNA replication and repair, apart from transcription. Intriguingly, FACT has been found to be upregulated in cancers while its downregulation leads to tumor cell death. However, the mechanism which fine-tunes FACT for normal cellular functions remained unknown. My studies revealed a novel mechanism of regulation of FACT by the ubiquitin-proteasome system in yeast. San1p, an E3 ligase involved in nuclear protein quality control, was found to associate with the active gene and regulate transcriptional elongation through its E3 ligase activity- mediated turnover of Spt16p component of FACT. This regulation was found to maintain optimum level of Spt16p/FACT to engage with the active gene for proper transcriptional elongation, DNA repair and replication. In spite of playing such crucial roles in gene regulation, it was not known how FACT is targeted to the active gene. We discovered that a direct physical interaction between FACT and Cet1p, the mRNA capping enzyme, targets FACT to the active gene independently of Cet1p’s mRNA capping activity. Such targeting of FACT to the active gene leads to the release of promoter proximally paused-RNAPII into transcriptional elongation. However, the progress of RNAPII along the active gene during transcriptional elongation is frequently impeded by various kinds of damages along the underlying template DNA. Even though some of these lesions are co-transcriptionally repaired, it was not known whether the repair of extremely toxic DNA double-strand breaks (DSBs) was coupled to transcription. My results showed that DSBs at the transcriptionally active state of a gene are repaired faster than at the inactive state but such repair was not mediated by a co-transcriptional recruitment of DSB repair factors. This observation is in contrast to other DNA repair pathways such as nucleotide excision repair (NER) where repair factors are co-transcriptionally recruited to the lesion containing DNA. In this regard, we found that an NER factor, Rad14p, co-transcriptionally associates with the active gene in the absence of DNA damage to promote transcription, which unraveled a new role of Rad14p in transcription in addition its established role in NER. In summary, my results provide significant novel insights into the regulation of transcriptional elongation and associated processes leading to better understanding of eukaryotic gene expression.

Les protéines du groupe Polycomb (PcG) ont initialement été identifiées chez la drosophile comme répresseurs transcriptionnels des gènes homéotiques. Aujourd’hui, nous savons que ces protéines jouent un rôle bien plus large puisqu’elles régulent des gènes dont les produits sont impliqués dans de nombreux processus biologiques (régulation des gènes HOX, maintien de la plasticité des cellules souches, la différenciation cellulaire, l’inactivation du chromosome X, la régulation des gènes soumis à empreintes). Leur dérégulation est source de nombreux cancers chez l’homme. Hautement conservées, elles forment deux principaux complexes : PRC 1 et 2 (Polycomb repressive complex 1 and 2), dont l’activité est respectivement reflétée par la mono-ubiquitinylation de la lysine 118 l’histone H2A (H2AK118Ub) et la tri-méthylation de la lysine 27 de l’histone H3 (H3K27me3). Chez la Drosophile, les sites de fixation de ces complexes sont appelés PRE (Polycomb Responsive Elements) où ils sont recrutés via des facteurs de transcription (FT).La complexité du recrutement des complexes du PcG, chez la Drosophile comme chez les mammifères, est visible à différents niveaux : au niveau de la séquence même de leurs sites de fixations, au niveau des facteurs de transcription qui les recrutent, au niveau de l’interface entre les deux complexes PRC1 et PRC2 et enfin au niveau global, part le présence de ces complexes au niveau de sites transcriptionnellement actifs. L’ensemble de ces résultats démontre clairement la nature hétérogène des PRE. Ces derniers diffèrent non seulement par leur séquence, mais également par les FT qui les recrutent et enfin par la manière dont les complexes PcG sont recrutés (PRC2 recrute PRC1 ou le contraire). Mon projet de thèse s’est donc dessiné autour d’une hypothèse : il existe différentes classes de PRE chez la Drosophile. Mon travail a donc consisté à définir ces différentes classes et à les caractériser pour en déduire des rôles spécifiques à l’échelle génomique. En effet, l’implication des complexes du PcG dans l’apparition de cancer chez l’Homme requière que l’on comprenne comment ces protéines sont recrutées à la chromatine.Mes travaux de thèse ont permis d’identifier six classes différentes de sites de fixation aux protéines du PcG. Nous avons retrouvé une classe correspondant aux sites de fixations canoniques fixés par les protéines du PcG et présents au sein de larges domaines répressifs marqués par H3K27me3. Une seconde classe correspond à des éléments de régulation marqués par un état de pause transcriptionnelle. De façon surprenante, nous avons démontré qu’une grande partie des sites de fixation des complexes du PcG était localisée au niveau de régions transcriptionnellement actives. Ces classes de PRE diffèrent en particulier en éléments génomiques qui les composent. Deux classes correspondent à des enhancers développementaux. Une classe correspond à des promoteurs actifs pouvant réguler des gènes de ménage. Enfin, une dernière classe correspond à des bordures de TAD. Les sites actifs et réprimés fixés par le PcG fixent également des combinaisons différentes de FT. Des analyses in vivo associées à un transcriptome réalisé à partir de cellules mutantes pour une protéine du PcG révèlent que les complexes du PcG jouent également un rôle de répresseur transcriptionnel au niveau des sites actifs. L’ensemble de ces résultats suggère une hétérogénéité inattendue des sites de fixation des complexes du PcG et permettra de mieux comprendre les caractéristiques liées à ces protéines dont la dérégulation mène à l’apparition de cancers chez l’Homme marqués par leur agressivité. / Polycomb group (PcG) complexes were initially discovered in Drosophila as transcriptionnal repressors of homeotic genes. To date, we know that they are involves in a large pleithora of biological processes including the maintenance of stem cells plasticity, differentiation, X chromosome inactivation and imprinting. PcG complexes are highly conserved from Drosophila to Humans and can be divided into two main complexes: PRC1 and PRC2 (Polycomb repressive complex 1 and 2). Both complexes have a histone modifying activity: PRC1 catalyses the mono-ubiquitination of the lysine 118 on histone H2A (H2AK118Ub) and PRC2 catalyses the tri-methylation of the lysine 27 on histone H3 (H3K27me3).In Drosophila, these complexes are recruited to cis regulatory elements named Polycomb Responsive Elements (PREs) that drive the epigenetic inheritance of silent chromatin states throughout development. Importantly, PcG complexes do not contain DNA-binding activity but are recruited to PREs via their interaction with Transcription Factors (TF) recognizing DNA motifs clustered at PREs. However the mechanism how PREs target PcG complexes is still not well understood due to the complexity of PcG recruitment, which is reflected at different levels: The DNA signature between PREs can differ significantly and several TF are implicated in PcG recruitment, but none of them is sufficient to recruit PcG complexes to PREs. Moreover PcG complexes can cooperate in different ways to stabilize each other’s binding. Finally, another layer of complexity is found at a more global level since PcG complexes do not only bind repressed sites, but they are also found at active regions.Therefore, our working hypothesis is that different classes of PREs exist in Drosophila. My PhD work was thus to define these different classes of PREs on a genome-wide scale and to functionally characterize them in order to get a complete molecular description of PRE function. Understanding how PcG complexes are recruited is of high importance, since deregulation of both, PcG complexes and their recruiting factors can led to cancer and diseases. My work led to the identification of six different classes of PREs that are characterized by different chromatin and genomic features. Interestingly the majority of PREs are associated with active genes that can be divided into housekeeping regulatory regions and developmental enhancers. In addition another class comprises bona fide chromatin domain boundaries. On the other hand PREs associated with repressed chromatin states shows features of previously described PREs and associate with repressed genes and PcG-associated histone marks. Finally another class comprises PREs that are likely in a poised chromatin state. We further demonstrated that PREs located at repressed and active regions differ in their combination of TF. In vivo analyses along with a transcriptomic analysis performed in cell lines mutated for a member of PcG complexes revealed that PcG complexes play a repressive role at both, active and repressed PREs.Taken together, our result suggest an unexpected heterogeneity of PREs and contributes to the better understanding of their characteristics and function.

Made available in DSpace on 2014-06-11T19:23:06Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-03-06Bitstream added on 2014-06-13T20:50:01Z : No. of bitstreams: 1 paulino_cg_me_araiq_parcial.pdf: 377640 bytes, checksum: 4179fe3f31573884cda8bcaeb0a9769b (MD5) / Alterações súbitas ou prolongadas no meio ambiente podem ter influências deletérias na composição do código da vida, o (DNA). A epigenética é a visão moderna da nossa interação com o meio em que vivemos. De acordo com a Organização Mundial de Saúde, “morte súbita” é aquela que acontece até 24 horas desde o início da sintomatologia. A morte súbita de causa cardíaca, definida como uma morte natural inesperada em pessoas sem antecedentes cardiovasculares pré-conhecidos (com carácter fatal) revela-se, em todos os estudos efetuados até o momento, como a principal causa de morte na atividade física, podendo acometer tanto recém-nascidos como adultos. Diversos genes foram identificados em associação a SQTL (síndrome do QT longo – doenças genéticas que causam arritmias cardíacas potencialmente fatais), onde 90% dos casos estão relacionados a mutações no gene responsável pelo canal de sódio SCN5A (locus LQT3) e no gene MTR. A metilação do DNA é uma alteração epigenética que atua na regulação da expressão gênica, e pode estar relacionada com a morte súbita de origem cardíaca. Na metilação do DNA ocorre a adição de um radical metil (CH3) no carbono 5 de citosina geralmente seguida por guanina (dinucleotídeo CpG), catalisada por enzimas DNA metiltransferases (DNMTs). Metodologias relativamente simples permitem o conhecimento da existência de metilação no DNA. O tratamento do DNA genômico com bissulfito de sódio converte as citosinas (C) não metiladas em uracilas (U), mas não afeta as citosinas (C) metiladas, procedendo a seguir à amplificação por PCR específica para metilação e sequenciamento dos produtos selecionados a partir do DNA tratado com bissulfito. Este estudo teve como objetivos investigar diferenças nos padrões de metilação que pudessem estar associados ao desenvolvimento... / Prolonged or sudden changes in the environment may have deleterious influences on the content of the code of life, the (DNA). Epigenetics is the modern view of our interaction with the environment in which we live. According to the World Health Organization, sudden death is that which happens within 24 hours from the onset of symptoms. Sudden death from cardiac causes, defined as an unexpected natural death in people without cardiovascular history foreknown (with fatal character) shows up in all studies performed to date, as the leading cause of death in physical activity can affect both newborns and adults. Several genes have been identified in association with LQTS (long QT syndrome - genetic diseases that cause potentially fatal cardiac arrhythmias), where 90% of cases are related to mutations in the gene responsible for the sodium channel SCN5A (LQT3 locus) and the MTR gene. DNA methylation is an epigenetic modification that acts in the regulation of gene expression, and may be related to sudden cardiac death. DNA methylation occurs on the addition of a methyl group (CH3) carbon-5 of cytosine generally followed by guanine (CpG dinucleotide), enzyme catalyzed DNA methyltransferases (DNMTs). Methodologies allow relatively simple knowledge of the existence of DNA methylation. The treatment of genomic DNA with sodium bisulfite converts cytosine (C) at uracilas unmethylated (U), but does not affect cytosines (C) methylated by making Following amplification by methylation specific PCR and sequencing of the products selected from DNA treated with bisulfite. This study aimed to investigate differences in methylation patterns that could be associated with the development and / or recurrence of cardiovascular diseases. Therefore we assessed the pattern of methylation in the promoter region of genes... (Complete abstract click electronic access below)

In most eukaryotes methylation of histone H3 on lysine 9 (H3K9me) is the key post-translational modification required for the assembly of constitutive heterochromatin at centromeres and other chromosomal regions. H3K9me is bound by the chromodomain proteins HP1/Swi6 and the Suv39/Clr4 H3K9 methyltransferase itself suggesting that, once established, H3K9me might act as an epigenetic mark that can transmit the chromatin state independently of the initiator signal. However, it has not been demonstrated that H3K9me does indeed act as an epigenetic mark. Fission yeast represents an excellent system to address this question since S. pombe lacks DNA methylation and H3K9me is catalysed by the unique, non-essential H3K9 methyltransferase Clr4. To determine whether H3K9me carries epigenetic properties it is important to uncouple H3K9me from genomic domains that have the intrinsic ability to recruit the heterochromatin machinery. One way to solve this problem is to isolate H3K9me from its original context and investigate whether at an ectopic site H3K9me can self-propagate through cell division. To accomplish this, we tethered regulatable TetR-Clr4 fusion protein at euchromatic loci in fission yeast. This resulted in the assembly of an extensive domain of H3K9me-dependent heterochromatin that is rapidly disassembled following TetR-Clr4 release. Strikingly, the inactivation of Epe1, a putative histone demethylase, is sufficient to maintain the silent H3K9me-dependent heterochromatin at the tethering sites through mitotic and meiotic cell divisions in absence of TetR-Clr4. These results indicate that H3K9me acts as an epigenetic mark to maintain heterochromatin domains; however, a regulatory mechanism dependent on Epe1 exists to actively remove H3K9me and thus prevent heterochromatin from being transmitted when assembled at inappropriate regions of the genome.

Long non-coding RNAs (lncRNAs) are increasingly recognized as important regulators of genomic processes and cellular specification. Many lncRNAs regulate chromatin by functionally impacting the epigenetic state through direct interactions with chromatin-modifying proteins. We developed a protocol to enrich for chromatin-lncRNA interactions and used this technique to identify several candidate lncRNAs that interact with the Polycomb group (PcG) proteins. Our immunoprecipitation protocol uses a crosslinked chromatin fraction as the input and employs stringent washes and cross-validation techniques to dramatically decrease mRNA signal (as a metric of transient interactions or false positives), and increase the dynamic range of conventional RNA immunoprecipitation protocols. Applying this protocol to the PRC1 component Bmi1, we have identified 11 PcG-interacting lncRNA candidates whose expression impacts the transcription of many other chromatin factors and PcG targets. We focus on knockdown of one lncRNA candidate, CAT7, which increases expression of several homeobox-containing transcription factors as well as chromatin interacting proteins, including Trithorax group proteins, Jumanji-domain containing proteins, and PcG-like proteins in HeLa cells. Consistent with the observed increase in gene expression, knockdown of CAT7 decreases PcG binding (Suz12, H3K27me3 and Bmi1) at the promoter of the homeodomain protein Mnx1, located at the boundary of an adjacent gene desert. During early motor neuron differentiation from embryonic stem cells, knockdown of CAT7 is accompanied by changes in expression of master regulators of neuronal specification: increased upregulation Mnx1, upregulation of Isl1, and downregulation of Irx3, as well as changes in expression to several other PcG-regulated targets. Overall, this protocol is the first of its kind to efficiently identify de novo interactions between the PcG proteins and lncRNAs which impact PcG binding or PcG target gene expression.

Although structurally unrelated, the human killer cell immunoglobulin-like (KIR) and the rodent lectin-like Ly49 receptors serve similar functional roles in natural killer (NK) cells. Moreover, both gene families display variegated and mostly mono-allelic expression patterns established at the transcriptional level. DNA methylation, but not histone modifications, has recently been shown to play an important role in maintenance of the expression patterns of KIR genes but the potential role of DNA methylation in the expression of Ly49 genes was unknown. My thesis focuses on the role of epigenetic modifications, especially DNA methylation, in the maintenance of mouse Ly49 gene expression. I show that hypomethylation of the region encompassing the main promoter of Ly49a and Ly49c in primary C57BL/6 (B6) mouse NK cells correlates with expression of these genes. Using B6 x BALB/c Fl hybrid mice, I demonstrate that the expressed allele of Ly49a is hypomethylated while the non-expressed allele is heavily methylated, indicating a role for epigenetics in maintaining mono-allelic Ly49 gene expression. Furthermore, the Ly49a promoter region is heavily methylated in fetal NK cells but variably methylated in non-lymphoid tissues. In apparent contrast to the KIR genes, I show that histone acetylation state of the promoter region strictly correlate with Ly49A and Ly49G expression status. Also, the instability of Ly49G expression on some lymphoid cell lines is at least in part due to changes in the level of histone acetylation of the promoter region. As for the activating Ly49 receptors, it seems that although DNA methylation levels of the promoter regions do correlate with the state of expression of these receptors, the pattern of DNA methylation is different from that of the inhibitory Ly49a and c genes. In conclusion, my results support a role for epigenetic mechanisms in the maintenance of Ly49 expression. Moreover, these epigenetic mechanisms appear to vary among the Ly49 genes and also differ from those governing KIR expression. / Medicine, Faculty of / Medical Genetics, Department of / Graduate

Genetics has been successful in associating DNA sequence variants to both dichotomous and continuous traits in a variety of organisms, from plant and farm animal studies to human disease. With the advent of high-throughput genotyping, there has been an almost routine gen- eration of genome-wide association studies (GWAS) between human disease traits and genomic regions. Despite this success, a particular frustration is that the majority of associated loci are in non-coding regions of the genome and thus interpretation is hard. To improve characterisation of non-coding regions, molecular as- says can be used as a phenotype, and subsequently be used to explain how genetics alter molecular mechanisms. In this thesis, the inter- play of three molecular assays that are involved in regulating gene expression is studied. On 60 individuals, several assays are performed: FAIRE-chip, CTCF- seq, RNA-seq and DNA-seq. In the first part, the discovery and characteristics of FAIRE-QTLs is presented. The identified FAIRE-QTLs show strong overlap with other molecular QTLs, histone modifications, and transcription factors. The second part consists of the integration of genome-wide molecu- lar assays in a human population to reconstruct the human epigenome. Each of the molecular assays is associated with each of the other assays to discover phenotype-to-phenotype correlations. Furthermore, QTL data are used to dissect the causality for these phenotype-to-phenotype correlations in a system genetic manner. The third part presents a comprehensive view of CTCF binding on the X chromosome, and its implications for X-chromosome inactivation. A novel X chromosome-wide CTCF effect is observed. Using the gender of each of the cell lines, observations are made about which CTCF sites are dosage-compensated, active on both chromosomes, or are only bound in females.

The dynamic changes in chromatin play a significant role in lineage commitment and differentiation. These epigenetic modifications control gene expression through recruitment of transcription factors. While the active mark H3K4me3 is present around the transcription start site on the gene, the function of the H3K36me3 mark is unknown. A number of H3K36-specific histone methyltransferases (HMTs) have been identified, however the focus of this study is the HMT Hypb. To elucidate the role of H3K36me3 in mediating expression of developmentally-regulated loci, native chromatin immunoprecipitation (N-ChIP) was performed at a subset of genes. Upon differentiation, we observe that H3K36me3 becomes enriched at the 3’ end of several muscle-specific genes. To further investigate the role of H3K36me3 in myogenesis, a lentiviral-mediated knockdown of the H3K36 HMT Hypb was performed in muscle myoblasts using shRNA. Upon Hypb knockdown, we were surprised to observe enhanced myogenesis. N-ChIP was also performed on differentiated Hypb knockdown cell lines in order to look at H3K36me3 enrichment on genes involved in muscle differentiation. N-ChIP data show a drop in H3K36me3 enrichment levels on myogenin and Ckm genes. The possible occupancy of Hypb on the coding regions of muscle-specific genes was experimentally observed by cross-linked chromatin immunoprecipitation (X-ChIP) on differentiated C2C12 cells and subsequently confirmed by X-ChIP on knockdown lines where the occupancy was lost. A model is proposed that links the observed phenotype with H3K36me3.